Smith Karen L

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Smith Karen L
CIK #0001639637
EDGAR Form CIK 2011 - 2026
3 [0001639637]
4 [0001639637]
Form 3/4/5 Subject 2011 - 2026
Context Therapeutics Inc
Smith Karen L
Skye Bioscience Inc
Sangamo Therapeutics Inc
Aurinia Pharmaceuticals Inc
Tourmaline Bio Inc
Quince Therapeutics Inc
Antares Pharma Inc
Acceleron Pharma Inc
Emergent BioSolutions Inc
Jazz Pharmaceuticals Inc
Sucampo Pharmaceuticals Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
2026-02-06 Grant 35,000 $0.00
Sangamo Therapeutics Inc SGMO
Common Stock
2025-06-12 Grant 25,000 $0.00
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
2025-06-12 Grant 123,500 $0.00
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
2025-06-12 Grant 50,000 $0.00
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
2025-02-24 Grant 35,000 $0.00
Aurinia Pharmaceuticals Inc AUPH
Common Shares
2024-11-21 Grant 12,135 $0.00
Aurinia Pharmaceuticals Inc AUPH
Director Stock Option (right to buy) · derivative
2024-11-21 Grant 18,641 $0.00
Aurinia Pharmaceuticals Inc AUPH
Common Stock
2024-11-11 Sell 5,241 $8.43 44,182
Aurinia Pharmaceuticals Inc AUPH
Common Stock
2024-11-08 Option exercise 17,913
Aurinia Pharmaceuticals Inc AUPH
Restricted Stock Units · derivative
2024-11-08 Option exercise 17,913 $0.00
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
2024-10-28 Grant 70,000 $0.00
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
2024-09-04 Grant 19,315 $0.00
Skye Bioscience Inc SKYE
Director Stock Option (Right to Buy) · derivative
2024-07-02 Grant 40,000 $0.00
Sangamo Therapeutics Inc SGMO
Common Stock
2024-06-04 Grant 25,000 $0.00
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
2024-06-04 Grant 50,000 $0.00
Aurinia Pharmaceuticals Inc AUPH
Stock Option (right to buy) · derivative
2023-08-18 Grant 28,959 $0.00
Aurinia Pharmaceuticals Inc AUPH
Restricted Stock Units · derivative
2023-08-18 Grant 17,913 $0.00
Tourmaline Bio Inc TALS
Stock Option (Right to Buy) · derivative
2023-06-13 Grant 20,500 $0.00
Sangamo Therapeutics Inc SGMO
Common Stock
2023-06-01 Grant 13,900 $0.00
Sangamo Therapeutics Inc SGMO
Stock Option (Right to Buy) · derivative
2023-06-01 Grant 27,750 $0.00
showing 20 of 112 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com